The Big Picture in 2026 In 2026, revenue leakage is no longer a back office inconvenience. It has become a material financial threat for medical practices and health systems.

For clinical laboratories, compliance risk is no longer confined to the legal department. It is now a core financial, operational, and enterprise risk.

Somewhere in your office right now, a staff member is on hold with a payer, faxing a clinical note for the third time, or refreshing a portal waiting on a prior authorization decision that should have arrived days ago. If that scene feels permanent, you are not wrong to be frustrated. Physicians and care teams complete an average of 39 prior authorization requests per physician per week, consuming at least 13 hours of staff time, according to AMA survey data.

For orthopedic practices, 2026 is not just another update year. It is a reset. Decisions about where care is delivered have always mattered clinically. Now they matter financially just as much. Medicare payment policy has made site of service a direct driver of reimbursement, and practices that do not adapt will feel it in quieter but very real ways.

At first glance, Medicare’s finalized conversion factor increase for 2026 looks like good news for orthopedic practices. Higher rates should mean higher revenue.

Laboratory reimbursement is back in the spotlight and the stakes are higher than ever before.

If there’s one frustration nearly every healthcare organization shares in 2026, it’s this:

For years, patient financial engagement was treated as a collections problem. In 2026, that framing is officially outdated.

In 2026, laboratory billing teams are facing a perfect storm.